U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EVA15 Insufflation Technology to Accommodate Higher Pressure Range
31 janv. 2023 09h00 HE
|
Palliare
Oceanside, CA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Palliare, a leading developer of advanced insufflation technologies, has received an expanded 510(k) indication from the U.S. Food and Drug...
RedDress’ ActiGraft® System Receives New FDA 510(k) Clearance
30 juin 2021 09h00 HE
|
RedDress
Ponte Vedra Beach, FL, June 30, 2021 (GLOBE NEWSWIRE) -- RedDress, a privately held U.S. and Israel-based wound care company, announced today that it has received U.S. Food and Drug Administration...
Akesis Galaxy® RTi SRS System Receives FDA Clearance
10 mars 2021 08h00 HE
|
Akesis
High-Precision Intracranial Gamma System to Treat Brain Diseases and Brain Cancer Has Integrated, Real-Time Imaging CONCORD, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- The Akesis...
PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device
21 avr. 2020 09h30 HE
|
PAVmed Inc.
NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has...
BioLargo Subsidiary Clyra Medical Technologies Receives FDA 510(k) Clearance
23 sept. 2019 09h00 HE
|
BioLargo, Inc.
WESTMINSTER, CA, Sept. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioLargo, Inc. (OTCQB: BLGO), developer of sustainable products and technologies and a full-service environmental engineering...